Description
Phase
Phase 2 - takes the treatment one step further, assessing the activity of a particular therapy in a disease, often building upon leads from the Phase I trial. While patients are generally required to be previously untreated, participation in a Phase II trial doesn't usually preclude the patient from getting the standard treatment after they've received the investigational agent. At best they are allowed to get a new drug they wouldn't be able to get otherwise that may turn out to be better for their disease.Inclusion and Exclusion Criteria
Please contact Anayansi Miloud to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- Children's Hospital Los Angeles, Los Angeles, California, 90027
- Sarcoma Oncology Center, Santa Monica, California, 90403
- UCLA/Mattel's Children's Hospital, Los Angeles, California, 90095
- USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, 90089
- Stanford University, Palo Alto, California, 94304
- UCSF, San Francisco, California, 94143
-
Washington
- Seattle Cancer Care Alliance/University of Washington Medical Center, Seattle, Washington, 98109
-
Tennessee
- St. Jude Children's Research Hospital, Memphis, Tennessee, 38105
-
Ohio
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229
Powered by
SC CTSI